Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
…, EPF Chow, S Cocchio, T Dalianis, SL Deeks… - The Lancet, 2019 - thelancet.com
Background More than 10 years have elapsed since human papillomavirus (HPV) vaccination
was implemented. We did a systematic review and meta-analysis of the population-level …
was implemented. We did a systematic review and meta-analysis of the population-level …
The basic reproduction number (R0) of measles: a systematic review
…, S Bolotin, G Lim, J Heffernan, SL Deeks… - The Lancet Infectious …, 2017 - thelancet.com
The basic reproduction number, R nought (R 0 ), is defined as the average number of
secondary cases of an infectious disease arising from a typical case in a totally susceptible …
secondary cases of an infectious disease arising from a typical case in a totally susceptible …
Human papillomavirus vaccine introduction–the first five years
LE Markowitz, V Tsu, SL Deeks, H Cubie, SA Wang… - Vaccine, 2012 - Elsevier
The availability of prophylactic human papillomavirus (HPV) vaccines has provided powerful
tools for primary prevention of cervical cancer and other HPV-associated diseases. Since …
tools for primary prevention of cervical cancer and other HPV-associated diseases. Since …
[HTML][HTML] The impact of infection on population health: results of the Ontario burden of infectious diseases study
…, MA Campitelli, N Daneman, SL Deeks… - 2012 - journals.plos.org
Background Evidence-based priority setting is increasingly important for rationally distributing
scarce health resources and for guiding future health research. We sought to quantify the …
scarce health resources and for guiding future health research. We sought to quantify the …
Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study
Background The possible risk of Guillain-Barré syndrome from influenza vaccines remains
a potential obstacle to achieving high vaccination coverage. However, influenza infection …
a potential obstacle to achieving high vaccination coverage. However, influenza infection …
Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990–2000
…, M Escobar, AM Newman, Y He, P Driezen, S Deeks… - Cmaj, 2003 - Can Med Assoc
Background: Since 1990, the Canadian Red Cross Society and Canadian Blood Services
have been testing blood donors for hepatitis C virus (HCV) antibody and HCV nucleic acids …
have been testing blood donors for hepatitis C virus (HCV) antibody and HCV nucleic acids …
Effectiveness of pertussis vaccination and duration of immunity
KL Schwartz, JC Kwong, SL Deeks, MA Campitelli… - Cmaj, 2016 - Can Med Assoc
Background: A resurgence of pertussis cases among both vaccinated and unvaccinated
people raises questions about vaccine effectiveness over time. Our objective was to study the …
people raises questions about vaccine effectiveness over time. Our objective was to study the …
The Australian Childhood Immunisation Register—A model for universal immunisation registers?
BP Hull, SL Deeks, PB McIntyre - Vaccine, 2009 - Elsevier
The Australian Childhood Immunisation Register (ACIR) was established in 1996 as an opt-out
register built on the platform of Medicare, the universal national health insurance scheme…
register built on the platform of Medicare, the universal national health insurance scheme…
Annualized incidence and spectrum of illness from an outbreak investigation of Bell's palsy
Background: There are limited clinical and epidemiological data on patients diagnosed with
Bell’s palsy. While investigating an apparent clustering of Bell’s palsy, we sought to …
Bell’s palsy. While investigating an apparent clustering of Bell’s palsy, we sought to …
Invasive pneumococcal disease among immunocompromised persons: implications for vaccination programs
…, S Richardson, D Tran, S Deeks… - Clinical Infectious …, 2016 - academic.oup.com
Background. In 2012/2013, a single dose of 13-valent pneumococcal conjugate vaccine (PCV13)
was recommended for immunocompromised adults in the United States and Canada. …
was recommended for immunocompromised adults in the United States and Canada. …